🔎 Trials Near Me

Inicio › Diabetes tipo 2 › Misuri

Ensayos clínicos de Diabetes tipo 2 en Misuri

20 estudios sobre Diabetes tipo 2 buscan participantes en Misuri.

Ciudades en Misuri

Texto oficial del estudio (inglés)

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  • Washington University School of Medicine, St Louis
  • Saint Louis Heart and Vascular, St Louis
ReclutandoSe aceptan voluntarios sanos
Edades de 55 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT06112418

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Kansas City
  • Research Site, Kansas City
  • Research Site, St Louis
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07784270

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Clinical Research Professionals, Chesterfield
  • Clinvest Headlands Llc, Springfield
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07282600

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  • StudyMetrix Research, LLC, City of Saint Peters
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07754461

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Columbia
  • AURORA-2 Clinical Site, St Louis
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT07743450

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Jefferson City Medical Group, Jefferson City
  • Johnson County ClinTrials, Kansas City
  • St. Louis Heart and Vascular, P.C., St Louis
  • y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT07064473

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Kansas City VA Medical Center, Kansas City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT07351058

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

  • Headlands Research, Springfield
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 11 sept 2026 · NCT07415954

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • Elixia MNA, City of Saint Peters
  • Clinical Research Consultants, LLC, Kansas City
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 11 sept 2026 · NCT07271186

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

  • Research Site, Jefferson City
  • Research Site, Kansas City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07662213

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

  • Alliance for Multispecialty Research - Kansas City, Kansas City
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 3 sept 2026 · NCT07684144

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

  • Research Site, Kansas City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT07662135

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  • Johnson County ClinTrials, Kansas City
  • Amicis Centers of Clinical Research, St Louis
ReclutandoFase 3
Edades de 45 en adelante · Todos los sexos · Actualizado el 1 sept 2026 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

  • Research Site, Kansas City
  • Research Site, St Louis
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 31 ago 2026 · NCT07662044

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

  • Jefferson City Medical Center, Jefferson City
  • Clay Platte Family Medicine, Kansas City
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 17 ago 2026 · NCT07527650

Role of KATP Channel Loss in Type 2 Diabetes

  • Washington University in St. Louis, St Louis
ReclutandoSe aceptan voluntarios sanos
Edades de 18 a 65 · Todos los sexos · Actualizado el 10 ago 2026 · NCT06830096

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity

  • University of Missouri School of Medicine, Columbia
ReclutandoSe aceptan voluntarios sanos
Edades de 18 a 70 · Todos los sexos · Actualizado el 6 ago 2026 · NCT06335771

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)

  • University of Missouri School of Medicine, Columbia
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 a 70 · Todos los sexos · Actualizado el 6 ago 2026 · NCT06571474

Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)

  • Washington University School of Medicine, St Louis
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 12 a 17 · Todos los sexos · Actualizado el 18 dic 2025 · NCT05277558

De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.